Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
STVN
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
DUBLIN, Oct. 1, 2026 /PRNewswire/ -- Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish speciali…
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
United Therapeutics (UTHR) shares ended the last trading session 12.5% higher at $541.89. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.1% lo…
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?
electroCore, Inc. (ECOR) shares rallied 6.9% in the last trading session to close at $11.38. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock'…
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
west pharmaceutical company in dublin By frank Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. Valued at $25…
Stevanato Group to Participate in Two Upcoming Investor Conferences
PIOMBINO DESE, Italy, September 08, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences…
Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth
On August 4, Stevanato Group (NYSE:STVN) reported second-quarter revenue of €302.0 million, up 8% year over year, while also closing the sale of its California-based subsidiary, Balda C. Brewer Inc. The results paired steady growth in the…
Riverwater Sees a Market Overreaction in Stevanato Group (STVN) After Oral GLP-1 Launches
Riverwater Partners, an investment management company, released its 'Small Cap Strategy' Q2 2026 investor letter. The letter can be downloaded here. The Small Cap Strategy underperformed the Russell 2000 in the second quarter as the benchm…
Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. What Stevanato Group's latest earnings and guidance mean for invest…
How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals
Stevanato Group S.p.A. recently reported past second-quarter 2026 results showing sales of €302 million with lower net income, slightly trimmed its full-year revenue guidance to €1.26–€1.28 billion, and outlined expected diluted EPS of €0.…
Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Stevanato Group stock has declined 34.6% over the past three years, and current checks send mixed v…
Is Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potent…
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Franco StevanatoChief Financial Officer - Marco Dal LagoChief Communications and IR Officer - Lisa Miles TAK…
Stevanato Group S.p.A. Q2 2026 Earnings Call Summary
Stevanato Group S.p.A. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Positioning Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our…
Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ...
This article first appeared on GuruFocus. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revenue grew 8% year-over-year, driven by a 9% inc…
Sage Park Acquires Balda C. Brewer, the California-based Contract Manufacturing Injection Molding Subsidiary From Stevanato Group S.p.A.
ANAHEIM, CA / ACCESS Newswire / August 4, 2026 / Craftech Holdco, a portfolio company of Sage Park, today announced the acquisition of Balda C. Brewer ("BCB"), the Ontario, California-based contract manufacturing subsidiary, from its paren…
Stevanato Group (STVN) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring item…
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026
- The Company Divests its California-Based Subsidiary, Balda C. Brewer, Inc - PIOMBINO DESE, Italy, August 04, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and di…
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
The regulatory approvals cover therapies for diabetes and weight management, further expanding the commercial adoption of Stevanato Group's proprietary Alina® pen injector platform across Europe. PIOMBINO DESE, Italy, July 30, 2026--(BUSIN…
Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to earnings of $0.86 per share a year ago. These figures are adjusted for non-recurring it…
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
PIOMBINO DESE, Italy, July 21, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences indus…
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
Profound Medical (PROF) shares soared 8.2% in the last trading session to close at $7.37. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.3% gain over the pas…
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN)
TimesSquare Capital Management, an equity investment management company, released its "U.S. Mid Cap Growth Strategy" first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Strategy fell 7.72% (net) in the quar…
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
Aurinia Pharmaceuticals (AUPH) shares ended the last trading session 6.5% higher at $17.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 8.2%…
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Stevanato Group stock overview after recent performance moves Stevanato Group (STVN) stock has be…
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now?
Is STVN a good stock to buy? We came across a bullish thesis on Stevanato Group S.p.A. on Best Anchor Stocks's Substack. In this article, we will summarize the bulls' thesis on STVN. Stevanato Group S.p.A.'s share was trading at $18.10 as…
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Shares of Cencora (NYSE: COR) and Stevanato Group (NYSE: STVN) are down more than 17% and 5%, respectively, so far this year. This is despite solid first-quarter earnings and steady business models. Cencora, formerly known as AmerisourceBe…
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL PIOMBINO DESE, Italy, June 08, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE:…
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
All Resolutions Proposed to Shareholders Passed PIOMBINO DESE, Italy, June 03, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) (the "Company"), a leading global provider of drug containment, drug delivery and diagnostic solution…
Implied Volatility Surging for Stevanato Stock Options
Investors in Stevanato Group S.p.A. STVN need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $35.00 Call had some of the highest implied volatility of all equity options t…
Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Investors in Stevanato Group S.p.A. (NYSE:STVN) had a good week, as its shares rose 6.1% to close at US$18.03 following the release of its first-quarter results. It looks like a credible result overall - although revenues of €274m were in…
Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Interim CEO — Lisa Miles CFO — Marco Dal Lago Full Conference Call Transcript So let's get started. Today, we'll review our first quarter performan…
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
Stevanato Group (STVN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring item…
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
- The Company Maintains Fiscal 2026 Guidance - PIOMBINO DESE, Italy, May 07, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmace…
A Look At Stevanato Group’s (NYSE:STVN) Valuation After Its Recent Share Price Rebound
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. How Stevanato Group stock has been trading recently Stevanato Group (NYSE:STVN) has drawn fresh attention after a sharp…
Madrigal (MDGL) came out with a quarterly loss of $3.25 per share versus the Zacks Consensus Estimate of a loss of $3.61. This compares to a loss of $3.32 per share a year ago. These figures are adjusted for non-recurring items. This quart…
Stevanato Group to Participate in Three Upcoming Investor Conferences
PIOMBINO DESE, Italy, May 04, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences indust…